Back
IFT
Infratil Limited
🇦🇺 ASX
📈 HIGH PRICE GROWTH
💸 FINANCIALS
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 23.91%
Annual Growth
5 years average annual capital growth
💰
1.71%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
36
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Infratil Ltd. is engaged in the ownership of an infrastructure business, which provides services to individuals and communities. The firm owns and operates infrastructure businesses and investments in New Zealand, Australia, the United States, Asia, United Kingdom, and Europe. Its segments include Gurin Energy Asia, Manawa Energy New Zealand, Mint Renewables Australasia, Wellington International Airport New Zealand, Qscan Group Australia, RHCNZ Medical Imaging New Zealand, One NZ New Zealand, Associates, and All other segments and corporate New Zealand. Gurin Energy, Manawa Energy and Mint Renewables are renewable generation investments; Wellington International Airport is an airport investment; Qscan Group and RHCNZ Medical Imaging are diagnostic imaging investments; and One NZ is a digital infrastructure investment. Associates comprises its investments, including CDC Data Centers, Fortysouth, Galileo, Kao Data, Longroad Energy and RetireAustralia. The company invests in renewables, digital infrastructure, healthcare, and airports.
📈 Performance
Price History
+257.14%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
1.71%
💰 Annual Dividend Earnings Per $1,000 invested**
$17.07
💰 Most Recent Dividend Franked Percentage Estimate
0.00%
💰 Average Dividend Franked Percentage Estimate
0.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of IFT, your last dividend payment(s) would have been:
$ 110.54
on Wed Jul 02 2025
$ 50.28
on Tue Dec 10 2024
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.16
0.00%
2023
$0.18
0.00%
2022
$0.17
0.00%
2021
$0.17
0.00%
2020
$0.15
0.00%
2019
$0.14
0.00%
2018
$0.15
0.00%
2017
$0.15
0.00%
2016
$0.19
0.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🍃 Environmental, Social and Governance scores ℹ️
🌳
Environmental Score
86
A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution
⚖️
Governance Score
38
An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.
🤓 Advanced information
Technical Info
💰 Price*
$9.88
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IFT
36
📊 Total Capital Earnings
$22K
🔃 Average investment frequency
36 weeks
💵 Average investment amount
$1,755
⏰ Last time a customer invested in IFT
3 days
IFT investor breakdown
💵 Income of investors
More than 200k
150k - 200k
12%
100k - 150k
23%
50k - 100k
28%
Less than 50k
33%
👶 Age of investors
18 - 25
26 - 34
44%
35 - 90
53%
🙋 Legal gender of investors
Female
36%
Male
64%
Pearlers who invest in IFT also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
7.87%
📊 Share price
$106.39 AUD
🇦🇺 AUSTRALIA
🧱 MATERIALS
💸 FINANCIALS
⛳️ DIVERSIFIED
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
16.50%
📊 Share price
$142.15 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
⛳️ DIVERSIFIED
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
21.76%
📊 Share price
$63.38 AUD
🇺🇸 UNITED STATES
📈 HIGH PRICE GROWTH
CSL
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.
🙌 Performance (5Yr p.a)
-3.30%
📊 Share price
$242.76 AUD
⚖️ HIGH GOVERNANCE
🕊️ SOCIALLY AWARE
🧬 BIOTECHNOLOGY
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
🙌 Performance (5Yr p.a)
13.11%
📊 Share price
$91.31 AUD
🌏 GLOBAL
🏭 INDUSTRIALS
🧱 MATERIALS
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
Want more shares? Try these...
🕊️
Social Score
75
An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.